Neuromodulation Market (by Technology, Applications Segment, Region and Company) and Forecast to 2021 - Global Analysis
The global neuromodulation market is poised to cross US$ 5 Billion mark by 2021. Neuromodulation is a technology that acts directly upon nerves. It is the alteration-or modulation-of nerve activity by delivering electrical or pharmaceutical agents directly to a target area. Neuromodulation devices and treatments are life changing. They affect every area of the body and treat nearly every disease or symptom from headaches to tremors to spinal cord damage to urinary incontinence. With such a broad therapeutic scope, and significant ongoing improvements in biotechnology, the neuromodulation is poised as a major growth industry for the next decade. The market growth is attributed to factors such as an increased adoption of neuromodulation devices, ageing population, rising prevalence of diseases relevant to neuromodulation, technological advancements and deal making activity globally. However, the factors such as regulatory standards and compliance, negative social perception and a dearth of skilled neurosurgeons are restraining the growth of neuromodulation market globally.
By Technology Neuromodulation Market Analysis - In terms of technology, Spinal cord stimulation (SCS) is the largest segment of the market and is mostly indicated for treatment of chronic pain. Deep brain stimulation (DBS) represents the second largest segment within the neuromodulation market being followed by Sacral nerve stimulation (SNS) at the third spot in 2015. The VNS segment stands at the fourth spot with around XX% share of the neuromodulation market in 2015.
By Applications Neuromodulation Market Analysis - In terms of applications, Chronic pain is the leading application segment of the neuromodulation market. The urinary and fecal incontinence market is the second largest application segment of the neuromodulation market. Refractory epilepsy holds third highest share of the neuromodulation market in 2015 being followed by Parkinson’s disease. The Gastroparesis and Essential Tremor applications segment are competing closely with each other to grab maximum share of the pie.
Neuromodulation Market Regional Analysis - Geographically, North America is at the forefront of neuromodulation innovation, accounting for lion’s share of the global neuromodulation market in 2015. Europe is the second leading region for neuromodulation market and it is likely to remain at this position throughout the forecasting period. Japan captured third highest share of the global neuromodulation market in 2015. While China and brazil are competing closely with each other to grab maximum share of the market. In Latin American countries, Mexico and Brazil represent significant market potential for neuromodulation manufacturers.
Neuromodulation Market Company Analysis - Medtronic has been the dominant market player in the global neuromodulation market. However, it is facing increased competition from other players operating in the neuromodulation market. Boston Scientific is the second leading player for neuromodulation market capturing XX% share in 2015. St. Jude Medical is the third largest player by market share in the overall neuromodulation market. While, LivaNova (Cyberonics) and Nevro Corp. stands at the fourth and fifth spot respectively in the global neuromodulation market space.
iGATE RESEARCH report titled “Neuromodulation Market (by Technology, Applications Segment, Region and Company) and Forecast to 2021 - Global Analysis” provides a comprehensive assessment of the fast-evolving, high-growth global neuromodulation market. This report covers various aspects of the neuromodulation market including Technological Segment, Applications Segment, Regional Market, Company Sales and Product Portfolio Analysis, Major Deals in Neuromodulation Market landscape, and Growth Drivers and Challenges influencing global neuromodulation market.
This 156 Page report with 63 Figures and 8 Tables has been analyzed from 7 viewpoints:
1. Global Neuromodulation Market and Forecast (2010 - 2021)
2. By Technology - Global Neuromodulation Market and Forecast (2010 - 2021)
3. By Applications Segment - Global Neuromodulation Market and Forecast (2010 - 2021)
4. Neuromodulation Market and Forecast - Regional Analysis (2010 - 2021)
5. Global Neuromodulation Market and Forecast - Company Analysis (2010 - 2021)
6. Global Neuromodulation Market - Major Deals
7. Global Neuromodulation Market - Driving Factors and Challenges
Global Neuromodulation Market and Forecast - 5 Technological Segments Covered
1. Spinal Cord Stimulation (SCS)
2. Deep Brain Stimulation (DBS)
3. Sacral Nerve Stimulation (SNS)
4. Vagus Nerve Stimulation (VNS)
5. Other Technologies
Global Neuromodulation Market and Forecast - 11 Applications Segment Covered
1. Chronic Pain
2. Urinary and Fecal Incontinence
3. Parkinson’s Disease
4. Refractory Epilepsy
5. Essential Tremor
6. Dystonia
7. Gastroparesis
8. Treatment Resistant Depression (TRD)
9. Obsessive Compulsive Disorder(OCD)
10. Intractable chronic migraine (ICM)
11. Other Applications
Neuromodulation Market and Forecast - 6 Regions Covered
1. North America
2. Europe
3. Japan
4. China
5. Latin America
6. Rest of the World
Global Neuromodulation Market and Forecast - 6 Companies Covered
1. Medtronic
2. Boston Scientific
3. St. Jude Medical
4. LivaNova (Cyberonics)
5. Nevro Corp
6. Others
Data Sources
iGATE RESEARCH employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports. This report is built by using data and information sourced from Proprietary Information Database, Primary and Secondary Research Methodologies, and In house analysis by iGATE Research dedicated team of qualified professionals with deep industry experience and expertise.
Research Methodologies
Primary Research Methodologies: Questionnaires, Surveys, Interviews with Individuals, Small Groups, Telephonic Interview, etc.
Secondary Research Methodologies: Printable and Non-printable sources, Newspaper, Magazine and Journal Content, Government and NGO Statistics, white Papers, Information on the Web, Information from Agencies Such as Industry Bodies, Companies Annual Report, Government Agencies, Libraries and Local Councils and a large number of Paid Databases.
By Technology Neuromodulation Market Analysis - In terms of technology, Spinal cord stimulation (SCS) is the largest segment of the market and is mostly indicated for treatment of chronic pain. Deep brain stimulation (DBS) represents the second largest segment within the neuromodulation market being followed by Sacral nerve stimulation (SNS) at the third spot in 2015. The VNS segment stands at the fourth spot with around XX% share of the neuromodulation market in 2015.
By Applications Neuromodulation Market Analysis - In terms of applications, Chronic pain is the leading application segment of the neuromodulation market. The urinary and fecal incontinence market is the second largest application segment of the neuromodulation market. Refractory epilepsy holds third highest share of the neuromodulation market in 2015 being followed by Parkinson’s disease. The Gastroparesis and Essential Tremor applications segment are competing closely with each other to grab maximum share of the pie.
Neuromodulation Market Regional Analysis - Geographically, North America is at the forefront of neuromodulation innovation, accounting for lion’s share of the global neuromodulation market in 2015. Europe is the second leading region for neuromodulation market and it is likely to remain at this position throughout the forecasting period. Japan captured third highest share of the global neuromodulation market in 2015. While China and brazil are competing closely with each other to grab maximum share of the market. In Latin American countries, Mexico and Brazil represent significant market potential for neuromodulation manufacturers.
Neuromodulation Market Company Analysis - Medtronic has been the dominant market player in the global neuromodulation market. However, it is facing increased competition from other players operating in the neuromodulation market. Boston Scientific is the second leading player for neuromodulation market capturing XX% share in 2015. St. Jude Medical is the third largest player by market share in the overall neuromodulation market. While, LivaNova (Cyberonics) and Nevro Corp. stands at the fourth and fifth spot respectively in the global neuromodulation market space.
iGATE RESEARCH report titled “Neuromodulation Market (by Technology, Applications Segment, Region and Company) and Forecast to 2021 - Global Analysis” provides a comprehensive assessment of the fast-evolving, high-growth global neuromodulation market. This report covers various aspects of the neuromodulation market including Technological Segment, Applications Segment, Regional Market, Company Sales and Product Portfolio Analysis, Major Deals in Neuromodulation Market landscape, and Growth Drivers and Challenges influencing global neuromodulation market.
This 156 Page report with 63 Figures and 8 Tables has been analyzed from 7 viewpoints:
1. Global Neuromodulation Market and Forecast (2010 - 2021)
2. By Technology - Global Neuromodulation Market and Forecast (2010 - 2021)
3. By Applications Segment - Global Neuromodulation Market and Forecast (2010 - 2021)
4. Neuromodulation Market and Forecast - Regional Analysis (2010 - 2021)
5. Global Neuromodulation Market and Forecast - Company Analysis (2010 - 2021)
6. Global Neuromodulation Market - Major Deals
7. Global Neuromodulation Market - Driving Factors and Challenges
Global Neuromodulation Market and Forecast - 5 Technological Segments Covered
1. Spinal Cord Stimulation (SCS)
2. Deep Brain Stimulation (DBS)
3. Sacral Nerve Stimulation (SNS)
4. Vagus Nerve Stimulation (VNS)
5. Other Technologies
Global Neuromodulation Market and Forecast - 11 Applications Segment Covered
1. Chronic Pain
2. Urinary and Fecal Incontinence
3. Parkinson’s Disease
4. Refractory Epilepsy
5. Essential Tremor
6. Dystonia
7. Gastroparesis
8. Treatment Resistant Depression (TRD)
9. Obsessive Compulsive Disorder(OCD)
10. Intractable chronic migraine (ICM)
11. Other Applications
Neuromodulation Market and Forecast - 6 Regions Covered
1. North America
2. Europe
3. Japan
4. China
5. Latin America
6. Rest of the World
Global Neuromodulation Market and Forecast - 6 Companies Covered
1. Medtronic
2. Boston Scientific
3. St. Jude Medical
4. LivaNova (Cyberonics)
5. Nevro Corp
6. Others
Data Sources
iGATE RESEARCH employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports. This report is built by using data and information sourced from Proprietary Information Database, Primary and Secondary Research Methodologies, and In house analysis by iGATE Research dedicated team of qualified professionals with deep industry experience and expertise.
Research Methodologies
Primary Research Methodologies: Questionnaires, Surveys, Interviews with Individuals, Small Groups, Telephonic Interview, etc.
Secondary Research Methodologies: Printable and Non-printable sources, Newspaper, Magazine and Journal Content, Government and NGO Statistics, white Papers, Information on the Web, Information from Agencies Such as Industry Bodies, Companies Annual Report, Government Agencies, Libraries and Local Councils and a large number of Paid Databases.
1. EXECUTIVE SUMMARY
2. GLOBAL - NEUROMODULATION MARKET AND FORECAST (2010 - 2021)
3. GLOBAL - NEUROMODULATION MARKET SHARE AND FORECAST (2010 - 2021)
3.1 Neuromodulation Market Share and Forecast - By Technology
3.2 Neuromodulation Market Share and Forecast - By Applications
3.3 Neuromodulation Market Share and Forecast - Regional Analysis
3.4 Neuromodulation Market Share and Forecast - Company Analysis
4. NEUROMODULATION MARKET AND FORECAST - BY TECHNOLOGY (2010 - 2021)
4.1 Spinal Cord Stimulation (SCS) Market Analysis
4.1.1 Spinal Cord Stimulation (SCS) Overview
4.1.2 Spinal Cord Stimulation (SCS) Market and Forecast
4.2 Deep Brain Stimulation (DBS) Market Analysis
4.2.1 Deep Brain Stimulation (DBS) Overview
4.2.2 Deep Brain Stimulation (DBS) Market and Forecast
4.3 Sacral Nerve Stimulation (SNS) Market Analysis
4.3.1 Sacral Nerve Stimulation (SNS) Overview
4.3.2 Sacral Nerve Stimulation (SNS) Market and Forecast
4.4 Vagus Nerve Stimulation (VNS) Market Analysis
4.4.1 Vagus Nerve Stimulation (VNS) Overview
4.4.2 Vagus Nerve Stimulation (VNS) Market and Forecast
4.5 Other Technologies Market and Forecast
5. NEUROMODULATION MARKET AND FORECAST - BY APPLICATIONS (2010 - 2021)
5.1 Chronic Pain Neuromodulation Market and Forecast
5.2 Urinary and Fecal Incontinence Neuromodulation Market and Forecast
5.3 Parkinson’s Disease Neuromodulation Market and Forecast
5.4 Refractory Epilepsy Neuromodulation Market and Forecast
5.5 Essential Tremor Neuromodulation Market and Forecast
5.6 Dystonia Neuromodulation Market and Forecast
5.7 Gastroparesis Neuromodulation Market and Forecast
5.8 Treatment Resistant Depression (TRD) Neuromodulation Market and Forecast
5.9 Obsessive Compulsive Disorder(OCD) Neuromodulation Market and Forecast
5.10 Intractable chronic migraine (ICM) Neuromodulation Market and Forecast
5.11 Other Applications Neuromodulation Market and Forecast
6. NEUROMODULATION MARKET AND FORECAST - REGIONAL ANALYSIS (2010 - 2021)
6.1 North America Neuromodulation Market and Forecast
6.2 Europe Neuromodulation Market and Forecast
6.3 Japan Neuromodulation Market and Forecast
6.4 China Neuromodulation Market and Forecast
6.5 Latin America Neuromodulation Market and Forecast
6.6 Rest of the World Neuromodulation Market and Forecast
7. NEUROMODULATION MARKET AND FORECAST - COMPANY ANALYSIS (2010 - 2021)
7.1 Medtronic
7.1.1 Business Overview
7.1.2 Medtronic - Neuromodulation Products Portfolio
7.1.3 Medtronic - Neuromodulation Revenue and Forecast
7.2 Boston Scientific
7.2.1 Business Overview
7.2.2 Boston Scientific - Neuromodulation Products Portfolio
7.2.3 Boston Scientific - Neuromodulation Revenue and Forecast
7.3 St. Jude Medical
7.3.1 Business Overview
7.3.2 St. Jude Medical - Neuroodulation Products Portfolio
7.3.3 St. Jude Medical - Neuromodulation Revenue and Forecast
7.4 LivaNova (Cyberonics)
7.4.1 Business Overview
7.4.2 LivaNova - Neuromodulation Products Portfolio
7.4.3 LivaNova - Neuromodulation Revenue and Forecast
7.5 Nevro Corp
7.5.1 Business Overview
7.5.2 Nevro Corp - Neuromodulation Products Portfolio
7.5.3 Nevro Corp - Neuromodulation Revenue and Forecast
7.6 Other Companies Neuromodulation Revenue and Forecast
8. GLOBAL NEUROMODULATION MARKET - MAJOR DEALS (2011 - 2016)
9. GLOBAL NEUROMODULATION MARKET - GROWTH DRIVERS
9.1 Rapid Technological Advancement Drives Neuromodulation Market
9.2 Increasing Prevalence of Diseases Relevant to Neuromodulation Fuels Market Growth
9.3 Ageing Population Drives Neuromodulation Market Growth
9.4 Expansion of Indications Drives the Growth of Neuromodulation Market
9.5 Emerging Neuromodulation Companies and Increasing Research and Development Activities
10. GLOBAL NEUROMODULATION MARKET - CHALLENGES
10.1 Regulatory Issues
10.2 Invasive Nature of Procedure and Negative Social Perception
10.3 Shortage of Skilled Professionals
2. GLOBAL - NEUROMODULATION MARKET AND FORECAST (2010 - 2021)
3. GLOBAL - NEUROMODULATION MARKET SHARE AND FORECAST (2010 - 2021)
3.1 Neuromodulation Market Share and Forecast - By Technology
3.2 Neuromodulation Market Share and Forecast - By Applications
3.3 Neuromodulation Market Share and Forecast - Regional Analysis
3.4 Neuromodulation Market Share and Forecast - Company Analysis
4. NEUROMODULATION MARKET AND FORECAST - BY TECHNOLOGY (2010 - 2021)
4.1 Spinal Cord Stimulation (SCS) Market Analysis
4.1.1 Spinal Cord Stimulation (SCS) Overview
4.1.2 Spinal Cord Stimulation (SCS) Market and Forecast
4.2 Deep Brain Stimulation (DBS) Market Analysis
4.2.1 Deep Brain Stimulation (DBS) Overview
4.2.2 Deep Brain Stimulation (DBS) Market and Forecast
4.3 Sacral Nerve Stimulation (SNS) Market Analysis
4.3.1 Sacral Nerve Stimulation (SNS) Overview
4.3.2 Sacral Nerve Stimulation (SNS) Market and Forecast
4.4 Vagus Nerve Stimulation (VNS) Market Analysis
4.4.1 Vagus Nerve Stimulation (VNS) Overview
4.4.2 Vagus Nerve Stimulation (VNS) Market and Forecast
4.5 Other Technologies Market and Forecast
5. NEUROMODULATION MARKET AND FORECAST - BY APPLICATIONS (2010 - 2021)
5.1 Chronic Pain Neuromodulation Market and Forecast
5.2 Urinary and Fecal Incontinence Neuromodulation Market and Forecast
5.3 Parkinson’s Disease Neuromodulation Market and Forecast
5.4 Refractory Epilepsy Neuromodulation Market and Forecast
5.5 Essential Tremor Neuromodulation Market and Forecast
5.6 Dystonia Neuromodulation Market and Forecast
5.7 Gastroparesis Neuromodulation Market and Forecast
5.8 Treatment Resistant Depression (TRD) Neuromodulation Market and Forecast
5.9 Obsessive Compulsive Disorder(OCD) Neuromodulation Market and Forecast
5.10 Intractable chronic migraine (ICM) Neuromodulation Market and Forecast
5.11 Other Applications Neuromodulation Market and Forecast
6. NEUROMODULATION MARKET AND FORECAST - REGIONAL ANALYSIS (2010 - 2021)
6.1 North America Neuromodulation Market and Forecast
6.2 Europe Neuromodulation Market and Forecast
6.3 Japan Neuromodulation Market and Forecast
6.4 China Neuromodulation Market and Forecast
6.5 Latin America Neuromodulation Market and Forecast
6.6 Rest of the World Neuromodulation Market and Forecast
7. NEUROMODULATION MARKET AND FORECAST - COMPANY ANALYSIS (2010 - 2021)
7.1 Medtronic
7.1.1 Business Overview
7.1.2 Medtronic - Neuromodulation Products Portfolio
7.1.3 Medtronic - Neuromodulation Revenue and Forecast
7.2 Boston Scientific
7.2.1 Business Overview
7.2.2 Boston Scientific - Neuromodulation Products Portfolio
7.2.3 Boston Scientific - Neuromodulation Revenue and Forecast
7.3 St. Jude Medical
7.3.1 Business Overview
7.3.2 St. Jude Medical - Neuroodulation Products Portfolio
7.3.3 St. Jude Medical - Neuromodulation Revenue and Forecast
7.4 LivaNova (Cyberonics)
7.4.1 Business Overview
7.4.2 LivaNova - Neuromodulation Products Portfolio
7.4.3 LivaNova - Neuromodulation Revenue and Forecast
7.5 Nevro Corp
7.5.1 Business Overview
7.5.2 Nevro Corp - Neuromodulation Products Portfolio
7.5.3 Nevro Corp - Neuromodulation Revenue and Forecast
7.6 Other Companies Neuromodulation Revenue and Forecast
8. GLOBAL NEUROMODULATION MARKET - MAJOR DEALS (2011 - 2016)
9. GLOBAL NEUROMODULATION MARKET - GROWTH DRIVERS
9.1 Rapid Technological Advancement Drives Neuromodulation Market
9.2 Increasing Prevalence of Diseases Relevant to Neuromodulation Fuels Market Growth
9.3 Ageing Population Drives Neuromodulation Market Growth
9.4 Expansion of Indications Drives the Growth of Neuromodulation Market
9.5 Emerging Neuromodulation Companies and Increasing Research and Development Activities
10. GLOBAL NEUROMODULATION MARKET - CHALLENGES
10.1 Regulatory Issues
10.2 Invasive Nature of Procedure and Negative Social Perception
10.3 Shortage of Skilled Professionals
LIST OF FIGURES:
Figure 2-1: Global - Neuromodulation Market (Million US$), 2010 - 2015
Figure 2-2: Global - Forecast for Neuromodulation Market (Million US$), 2016 - 2021
Figure 3-1: By Technology - Neuromodulation Market Share (Percent), 2010 - 2015
Figure 3-2: By Technology - Forecast for Neuromodulation Market Share (Percent), 2016 - 2021
Figure 3-3: By Company - Neuromodulation Market Share (Percent), 2010 - 2015
Figure 3-4: By Company - Forecast for Neuromodulation Market Share (Percent), 2016 - 2021
Figure 4-1: Global - Spinal Cord Stimulation (SCS) Market (Million US$), 2010 - 2015
Figure 4-2: Global - Forecast for Spinal Cord Stimulation (SCS) Market (Million US$), 2016 - 2021
Figure 4-3: By Company - Spinal Cord Stimulation (SCS) Market Share (Percent), 2015
Figure 4-4: Global - Deep Brain Stimulation (DBS) Market (Million US$), 2010 - 2015
Figure 4-5: Global - Forecast for Deep Brain Stimulation (DBS) Market (Million US$), 2016 - 2021
Figure 4-6: By Company - Deep Brain Stimulation (DBS) Market Share (Percent), 2015
Figure 4-7: Global - Sacral Nerve Stimulation (SNS) Market (Million US$), 2010 - 2015
Figure 4-8: Global - Forecast for Sacral Nerve Stimulation (SNS) Market (Million US$), 2016 - 2021
Figure 4-9: Global - Vagus Nerve Stimulation (VNS) Market (Million US$), 2010 - 2015
Figure 4-10: Global - Forecast for Vagus Nerve Stimulation (VNS) Market (Million US$), 2016 - 2021
Figure 4-11: Global - Other Technologies Market (Million US$), 2010 - 2015
Figure 4-12: Global - Forecast for Other Technologies Market (Million US$), 2016 - 2021
Figure 5-1: Global - Chronic Pain Neuromodulation Market (Million US$), 2010 - 2015
Figure 5-2: Global - Forecast for Chronic Pain Neuromodulation Market (Million US$), 2016 - 2021
Figure 5-3: Global - Urinary and Fecal Incontinence Neuromodulation Market (Million US$), 2010 - 2015
Figure 5-4: Global - Forecast for Urinary and Fecal Incontinence Neuromodulation Market (Million US$), 2016 - 2021
Figure 5-5: Global - Parkinson’s Disease Neuromodulation Market (Million US$), 2010 - 2015
Figure 5-6: Global - Forecast for Parkinson’s Disease Neuromodulation Market (Million US$), 2016 - 2021
Figure 5-7: Global - Refractory Epilepsy Neuromodulation Market (Million US$), 2010 - 2015
Figure 5-8: Global - Forecast for Refractory Epilepsy Neuromodulation Market (Million US$), 2016 - 2021
Figure 5-9: Global - Essential Tremor Neuromodulation Market (Million US$), 2010 - 2015
Figure 5-10: Global - Forecast for Essential Tremor Neuromodulation Market (Million US$), 2016 - 2021
Figure 5-11: Global - Dystonia Neuromodulation Market (Million US$), 2010 - 2015
Figure 5-12: Global - Forecast for Dystonia Neuromodulation Market (Million US$), 2016 - 2021
Figure 5-13: Global - Gastroparesis Neuromodulation Market (Million US$), 2010 - 2015
Figure 5-14: Global - Forecast for Gastroparesis Neuromodulation Market (Million US$), 2016 - 2021
Figure 5-15: Global - Treatment Resistant Depression (TRD) Neuromodulation Market (Million US$), 2010 - 2015
Figure 5-16: Global - Forecast for Treatment Resistant Depression (TRD) Neuromodulation Market (Million US$), 2016 - 2021
Figure 5-17: Global - Obsessive Compulsive Disorder(OCD) Neuromodulation Market (Million US$), 2010 - 2015
Figure 5-18: Global - Forecast for Obsessive Compulsive Disorder(OCD) Neuromodulation Market (Million US$), 2016 - 2021
Figure 5-19: Global - Intractable chronic migraine (ICM) Neuromodulation Market and Forecast (Million US$), 2015 - 2021
Figure 5-20: Global - Other Applications Neuromodulation Market (Million US$), 2011 - 2015
Figure 5-21: Global - Forecast for Other Applications Neuromodulation Market (Million US$), 2016 - 2021
Figure 6-1: North America - Neuromodulation Market (Million US$), 2010 - 2015
Figure 6-2: North America - Forecast for Neuromodulation Market (Million US$), 2016 - 2021
Figure 6-3: Europe - Neuromodulation Market (Million US$), 2010 - 2015
Figure 6-4: Europe - Forecast for Neuromodulation Market (Million US$), 2016 - 2021
Figure 6-5: Japan - Neuromodulation Market (Million US$), 2010 - 2015
Figure 6-6: Japan - Forecast for Neuromodulation Market (Million US$), 2016 - 2021
Figure 6-7: China - Neuromodulation Market (Million US$), 2010 - 2015
Figure 6-8: China - Forecast for Neuromodulation Market (Million US$), 2016 - 2021
Figure 6-9: Latin America - Neuromodulation Market (Million US$), 2010 - 2015
Figure 6-10: Latin America - Forecast for Neuromodulation Market (Million US$), 2016 - 2021
Figure 6-11: Rest of the World - Neuromodulation Market (Million US$), 2010 - 2015
Figure 6-12: Rest of the World - Forecast for Neuromodulation Market (Million US$), 2016 - 2021
Figure 7-1: Medtronic - Neuromodulation Revenue (Million US$), 2010 - 2015
Figure 7-2: Medtronic - Forecast for Neuromodulation Revenue (Million US$), 2016 - 2021
Figure 7-3: Boston Scientific - Neuromodulation Revenue (Million US$), 2010 - 2015
Figure 7-4: Boston Scientific - Forecast for Neuromodulation Revenue (Million US$), 2016 - 2021
Figure 7-5: St. Jude Medical - Neuromodulation Revenue (Million US$), 2010 - 2015
Figure 7-6: St. Jude Medical - Forecast for Neuromodulation Revenue (Million US$), 2016 - 2021
Figure 7-7: LivaNova - Neuromodulation Revenue (Million US$), 2010 - 2015
Figure 7-8: LivaNova - Forecast for Neuromodulation Revenue (Million US$), 2016 - 2021
Figure 7-9: Nevro Corp - Neuromodulation Revenue (Million US$), 2012 - 2015
Figure 7-10: Nevro Corp - Forecast for Neuromodulation Revenue (Million US$), 2016 - 2021
Figure 7-11: Other Companies - Neuromodulation Revenue and Forecast (Million US$), 2015 - 2021
Figure 9-1: Global - Ageing Population and Forecast (Million), 2010 - 2050
Figure 2-1: Global - Neuromodulation Market (Million US$), 2010 - 2015
Figure 2-2: Global - Forecast for Neuromodulation Market (Million US$), 2016 - 2021
Figure 3-1: By Technology - Neuromodulation Market Share (Percent), 2010 - 2015
Figure 3-2: By Technology - Forecast for Neuromodulation Market Share (Percent), 2016 - 2021
Figure 3-3: By Company - Neuromodulation Market Share (Percent), 2010 - 2015
Figure 3-4: By Company - Forecast for Neuromodulation Market Share (Percent), 2016 - 2021
Figure 4-1: Global - Spinal Cord Stimulation (SCS) Market (Million US$), 2010 - 2015
Figure 4-2: Global - Forecast for Spinal Cord Stimulation (SCS) Market (Million US$), 2016 - 2021
Figure 4-3: By Company - Spinal Cord Stimulation (SCS) Market Share (Percent), 2015
Figure 4-4: Global - Deep Brain Stimulation (DBS) Market (Million US$), 2010 - 2015
Figure 4-5: Global - Forecast for Deep Brain Stimulation (DBS) Market (Million US$), 2016 - 2021
Figure 4-6: By Company - Deep Brain Stimulation (DBS) Market Share (Percent), 2015
Figure 4-7: Global - Sacral Nerve Stimulation (SNS) Market (Million US$), 2010 - 2015
Figure 4-8: Global - Forecast for Sacral Nerve Stimulation (SNS) Market (Million US$), 2016 - 2021
Figure 4-9: Global - Vagus Nerve Stimulation (VNS) Market (Million US$), 2010 - 2015
Figure 4-10: Global - Forecast for Vagus Nerve Stimulation (VNS) Market (Million US$), 2016 - 2021
Figure 4-11: Global - Other Technologies Market (Million US$), 2010 - 2015
Figure 4-12: Global - Forecast for Other Technologies Market (Million US$), 2016 - 2021
Figure 5-1: Global - Chronic Pain Neuromodulation Market (Million US$), 2010 - 2015
Figure 5-2: Global - Forecast for Chronic Pain Neuromodulation Market (Million US$), 2016 - 2021
Figure 5-3: Global - Urinary and Fecal Incontinence Neuromodulation Market (Million US$), 2010 - 2015
Figure 5-4: Global - Forecast for Urinary and Fecal Incontinence Neuromodulation Market (Million US$), 2016 - 2021
Figure 5-5: Global - Parkinson’s Disease Neuromodulation Market (Million US$), 2010 - 2015
Figure 5-6: Global - Forecast for Parkinson’s Disease Neuromodulation Market (Million US$), 2016 - 2021
Figure 5-7: Global - Refractory Epilepsy Neuromodulation Market (Million US$), 2010 - 2015
Figure 5-8: Global - Forecast for Refractory Epilepsy Neuromodulation Market (Million US$), 2016 - 2021
Figure 5-9: Global - Essential Tremor Neuromodulation Market (Million US$), 2010 - 2015
Figure 5-10: Global - Forecast for Essential Tremor Neuromodulation Market (Million US$), 2016 - 2021
Figure 5-11: Global - Dystonia Neuromodulation Market (Million US$), 2010 - 2015
Figure 5-12: Global - Forecast for Dystonia Neuromodulation Market (Million US$), 2016 - 2021
Figure 5-13: Global - Gastroparesis Neuromodulation Market (Million US$), 2010 - 2015
Figure 5-14: Global - Forecast for Gastroparesis Neuromodulation Market (Million US$), 2016 - 2021
Figure 5-15: Global - Treatment Resistant Depression (TRD) Neuromodulation Market (Million US$), 2010 - 2015
Figure 5-16: Global - Forecast for Treatment Resistant Depression (TRD) Neuromodulation Market (Million US$), 2016 - 2021
Figure 5-17: Global - Obsessive Compulsive Disorder(OCD) Neuromodulation Market (Million US$), 2010 - 2015
Figure 5-18: Global - Forecast for Obsessive Compulsive Disorder(OCD) Neuromodulation Market (Million US$), 2016 - 2021
Figure 5-19: Global - Intractable chronic migraine (ICM) Neuromodulation Market and Forecast (Million US$), 2015 - 2021
Figure 5-20: Global - Other Applications Neuromodulation Market (Million US$), 2011 - 2015
Figure 5-21: Global - Forecast for Other Applications Neuromodulation Market (Million US$), 2016 - 2021
Figure 6-1: North America - Neuromodulation Market (Million US$), 2010 - 2015
Figure 6-2: North America - Forecast for Neuromodulation Market (Million US$), 2016 - 2021
Figure 6-3: Europe - Neuromodulation Market (Million US$), 2010 - 2015
Figure 6-4: Europe - Forecast for Neuromodulation Market (Million US$), 2016 - 2021
Figure 6-5: Japan - Neuromodulation Market (Million US$), 2010 - 2015
Figure 6-6: Japan - Forecast for Neuromodulation Market (Million US$), 2016 - 2021
Figure 6-7: China - Neuromodulation Market (Million US$), 2010 - 2015
Figure 6-8: China - Forecast for Neuromodulation Market (Million US$), 2016 - 2021
Figure 6-9: Latin America - Neuromodulation Market (Million US$), 2010 - 2015
Figure 6-10: Latin America - Forecast for Neuromodulation Market (Million US$), 2016 - 2021
Figure 6-11: Rest of the World - Neuromodulation Market (Million US$), 2010 - 2015
Figure 6-12: Rest of the World - Forecast for Neuromodulation Market (Million US$), 2016 - 2021
Figure 7-1: Medtronic - Neuromodulation Revenue (Million US$), 2010 - 2015
Figure 7-2: Medtronic - Forecast for Neuromodulation Revenue (Million US$), 2016 - 2021
Figure 7-3: Boston Scientific - Neuromodulation Revenue (Million US$), 2010 - 2015
Figure 7-4: Boston Scientific - Forecast for Neuromodulation Revenue (Million US$), 2016 - 2021
Figure 7-5: St. Jude Medical - Neuromodulation Revenue (Million US$), 2010 - 2015
Figure 7-6: St. Jude Medical - Forecast for Neuromodulation Revenue (Million US$), 2016 - 2021
Figure 7-7: LivaNova - Neuromodulation Revenue (Million US$), 2010 - 2015
Figure 7-8: LivaNova - Forecast for Neuromodulation Revenue (Million US$), 2016 - 2021
Figure 7-9: Nevro Corp - Neuromodulation Revenue (Million US$), 2012 - 2015
Figure 7-10: Nevro Corp - Forecast for Neuromodulation Revenue (Million US$), 2016 - 2021
Figure 7-11: Other Companies - Neuromodulation Revenue and Forecast (Million US$), 2015 - 2021
Figure 9-1: Global - Ageing Population and Forecast (Million), 2010 - 2050
LIST OF TABLES:
Table 3-1: By Applications - Neuromodulation Market Share (Percent), 2010 - 2015
Table 3-2: By Applications - Forecast for Neuromodulation Market Share (Percent), 2016 - 2021
Table 3-3: By Region - Neuromodulation Market Share (Percent), 2010 - 2015
Table 3-4: By Region - Forecast for Neuromodulation Market Share (Percent), 2016 - 2021
Table 4-1: Sacral Nerve Stimulation (SNS) FDA Approved Indication by Year of Approval
Table 8-1: Global Neuromodulation Market - Major Deals (2011 - 2016)
Table 9-1: United States: Prevalence of Therapeutic Areas Relevant to Neuromodulation (Million), 2014 - 2025
Table 9-2: Global - List of Emerging Neuromodulation Companies
Table 3-1: By Applications - Neuromodulation Market Share (Percent), 2010 - 2015
Table 3-2: By Applications - Forecast for Neuromodulation Market Share (Percent), 2016 - 2021
Table 3-3: By Region - Neuromodulation Market Share (Percent), 2010 - 2015
Table 3-4: By Region - Forecast for Neuromodulation Market Share (Percent), 2016 - 2021
Table 4-1: Sacral Nerve Stimulation (SNS) FDA Approved Indication by Year of Approval
Table 8-1: Global Neuromodulation Market - Major Deals (2011 - 2016)
Table 9-1: United States: Prevalence of Therapeutic Areas Relevant to Neuromodulation (Million), 2014 - 2025
Table 9-2: Global - List of Emerging Neuromodulation Companies
